Northwest Biotherapeutics Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Northwest Biotherapeutics Inc.

NWBO 0.250

+4.2%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: John McCarthy	12/21/2007 7:27:37 AM
	of 759

Company Northwest Biotherapeutics Inc TIDM NWBS Headline Registration Statement Update Released 18:25 18-Dec-07 Number 2249K RNS Number:2249K Northwest Biotherapeutics Inc 18 December 2007 For Immediate Release 18 December 2007 Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") Company files Updated registration Statement with SEC BETHESDA, MD - 18 December 2007: Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC BB: NWBO) today announced that on 17 December 2007 it filed Post-Effective Amendment No. 1 to an S-1 Registration Statement with the U.S. Securities and Exchange Commission ("SEC"). This amendment to the Registration Statement, which was originally filed on 17 July 2006 to register for sale stock and related warrants issued through a securities purchase agreement completed in March 2006, updates disclosure to reflect current securities filings including the Annual Report on Form 10-K for the year ended 31 December 2006 and Quarterly Reports on Form 10-Q for the first three quarters of 2007. A link to this document is www.rns-pdf.londonstockexchange.com/rns/2249k_-2007-12-18.pdf For further information, please contact: Northwest Biotherapeutics, Inc. Anthony P. Deasey, Chief Financial Officer +1 240-497-9024 Buchanan Communications Lisa Baderoon (lisab@buchanan.uk.com) / Mary-Jane Johnson / Catherine Breen +44 (0)20 7466 5000 Collins Stewart Europe Limited Tim Mickley / Adam Cowen +44 (0)20 7523 8350 This information is provided by RNS The company news service from the London Stock Exchange END londonstockexchange.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next